Home›Companies›Healthcare›EvoEndo

EvoEndo, Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 16, 2024·Suggest an edit

About EvoEndo

EvoEndo is a private company based in Centennial, Colorado. It has reported $4,700,000 raised in three offerings on Form D since March 2018. Its chief executive is Jonathan Hartmann.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 2, 2024Aug 16, 2024$2,250,000of $3.0M target4$562KDebt, OptionsRule 506(b)Form D ↗
Dec 6, 2019Dec 16, 2019$1,950,000of $2.5M target5$390KDebt, OptionsRule 506(b)Form D ↗
Feb 23, 2018Mar 9, 2018$500,000fully sold3$166KDebtRule 506(b), 4a5Form D ↗
Total, three offerings$4,700,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on EvoEndo's Form D filed Aug 16, 2024.

BL
Betsy Lahue
Director
DB
CR
JH
JF
Joel Friedlander
Executive officer and director
JH
Jonathan Hartmann
Chief Executive Officer and director
CT
Carl Traynor
Director
DP
David Pierce
Director
RH
Ryan Hartman
Executive officer

Earlier filings also listed Robin Deterding (vice president and director, last listed Dec 2019), Jeremy Prager (director, last listed Dec 2019) and Emily DeBoer (director, last listed Dec 2019).

Sources

  1. SECEvoEndo, Inc. filing history